News
In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...
Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...
Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...
They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...
Eli Lilly’s Zepbound transformed weight loss drug market since debut 18 months ago 4.5 million people reportedly taking Lilly ...
Massachusetts health insurers are effectively telling the drug companies that they may seek a rapidly growing customer base ...
Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...
I hear a lot of talk around our small town when someone becomes noticeably thinner. “He sure has lost a lot of weight.” “Did ...
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
Some people might have an allergic reaction at the injection site for one medication or have ... This all changed once she started Zepbound. “I feel better. I’m not as bloated. My movement is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results